Lazard Asset Management
BVS icon

Lazard Asset Management’s Bioventus BVS Stock Holding History

Lazard Asset Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.99M Buy
317,208
+11,691
+4% +$112K ﹤0.01% 798
2026
Q1 		$2.79M Buy
305,517
+35,008
+13% +$294K ﹤0.01% 759
2025
Q4 		$2.01M Buy
270,509
+136,388
+102% +$980K ﹤0.01% 861
2025
Q3 		$897K Buy
134,121
+59,202
+79% +$411K ﹤0.01% 1174
2025
Q2 		$495K Buy
74,919
+65,410
+688% +$464K ﹤0.01% 1497
2025
Q1 		$87K Sell
9,509
-1,009
-10% -$10.1K ﹤0.01% 1841
2024
Q4 		$110K Sell
10,518
-2,098
-17% -$24.8K ﹤0.01% 1778
2024
Q3 		$150K Buy
12,616
+26
+0.2% +$225 ﹤0.01% 1674
2024
Q2 		$72K Buy
12,590
+4,844
+63% +$26.6K ﹤0.01% 1849
2024
Q1 		$40K Buy
+7,746
New +$37.9K ﹤0.01% 1762
2022
Q3 		– Sell
-7,007
Closed -$47K – 2319
2022
Q2 		$47K Buy
7,007
+3,875
+124% +$39.5K ﹤0.01% 1840
2022
Q1 		$44K Buy
3,132
+1,733
+124% +$23.2K ﹤0.01% 1803
2021
Q4 		$20K Buy
+1,399
New +$19.9K ﹤0.01% 2044

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lazard Asset Management's BVS Position: Q2 2026 in Review

Lazard Asset Management increased its Bioventus (BVS) stake by 3.8% in Q2 2026, buying an estimated $112K and bringing the position to 317,208 shares worth $2.99M. The position accounts for ﹤0.01% of the portfolio, ranked #798.

Lazard Asset Management first reported a position in BVS in Q4 2021 and has held it in 13 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Lazard Asset Management held 317,208 shares of Bioventus worth $2.99M as of Q2 2026.
  • Lazard Asset Management bought 11,691 Bioventus shares in Q2 2026, an estimated $112K.
  • Bioventus made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #798 holding.
  • Lazard Asset Management first reported a position in Bioventus in Q4 2021 and has held it in 13 quarters since.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.